Comparison of two systemic steroid regimens for the treatment of COPD exacerbations
- 30 April 2014
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 27 (2) , 179-183
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Association of Corticosteroid Dose and Route of Administration With Risk of Treatment Failure in Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseJAMA, 2010
- Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2003
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Comparison of Nebulized Budesonide and Oral Prednisolone with Placebo in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Controlled TrialAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Systemic Glucocorticoids in Severe Exacerbations of COPDChest, 2001
- Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1999
- Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Outcomes Following Acute Exacerbation of Severe Chronic Obstructive Lung Disease. The SUPPORT Investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)American Journal of Respiratory and Critical Care Medicine, 1996
- Controlled Trial of Oral Prednisone in Outpatients With Acute COPD ExacerbationAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Pharmacokinetics of intravenous and oral prednisolone.British Journal of Clinical Pharmacology, 1980